Institute of Biomedical and Biomolecular Science (IBBS)

Molecular and genetic medicine

ibbs-molecular-med-conferen.jpgConferences

Selected recent presentations

  1. Lien C-F and Górecki DC. A destabilised dystrophin-associated protein complex at blood-brain barrier lacking alpha-dystrobrevin. 13th Annual Meeting of the LARC-Neuroscience network, October 30, 2009. Caen-France. (Podium presentation).
  2. Masin M, Barnes S, Marschall V, Young C, Lim K, Xu X, Górecki DC, Murrell-Lagnado R. Analysis of the assembly, expression and function of C-terminal truncated spliced variants of the mouse P2X7 receptor. UK Purine Mini-Symposium, November 19, 2009, Sheffield.
  3. Young C, Arkle S, Górecki DC. Purinergic receptors in the pathology of Duchenne Muscular Dystrophy 13th Annual Meeting of the LARC-Neuroscience network, October 30, 2009. Caen-France.
  4. Beręsewicz M, Majewska M, Dłużniewska J, Lien C-F, Makarewicz D., Vayro S, Zabłocka B and Górecki DC. Expression of IGF-1 variants in the postnatal brain development abd after hypoxia-ischaemia in neonatal and adult brain. 13th Annual Meeting of the LARC-Neuroscience network, October 30, 2009. Caen-France.
  5. Young C, Brutkowski W, Lien C-F, Arkle S, Zablocki K, Górecki DC. (Invited speaker). P2 receptors of skeletal muscle. XXIV FeSBE Meeting, Aguas de Lindoia, Sao Paulo, Brazil, 19-22 August 2009.
  6. Boumechache M, Masin M, Paramavisam A, Fagg L, Górecki DC, Murrell-Lagnado R. The assembly & distribution of P2X4 & P2X7 receptors. PURINES 2008, Copenhagen, Denmark, June 29 - July 2, 2008.
  7. Birks SM, Danquah J, Hitchman R, King L, Vlasak R, Górecki DC, Pilkington GJ. Manipulation of glioma cell surface gangliosides: Potential therapeutic implications. British Neurooncology Society Meeting, June 25-27, Preston, UK. Abstract in British Journal of Neurosurgery (Vol 22, number 3, June 2008).
  8. Jiang T, Yeung D, Lien C-F, Brutkowski W, Okoli U, Orecchioni S, Bogeas A, Cohen A, Arkle S, Lochmuller H, Barnard E A, Zabłocki K, Górecki DC. Nucleotide receptors of dystrophin-deficient skeletal muscle: relationship to dystrophic pathology and potential target for therapy. VLI Congress Anatomical and Histological Society, Sassari, Italy, 19-22 Sept. 2007. (Invited speaker).
  9. Górecki DC, Lavigne MD, Yates LL. Enhanced therapeutic gene expression in mucle in vivo using a nuclear targeting vector system based on the TAT-tagged EcoR124I. XIV Annual Congress of the European Society of Gene Therapy, Athens, Greece, 9-12 Nov. 2006.

ibbs-molecular-med-confere2.jpgPhD Presentations

We also do it at home. Every year we organize an event during which PhD students have a chance to present and discuss their results. The best talk and poster are awarded, with Promega UK sponsoring the Prize for the best oral presentation.